As­traZeneca culls its neu­ro­science team, ex­its Kendall Square of­fice

It turns out that As­traZeneca has been us­ing its prun­ing shears on staff in Cam­bridge, MA as well as down in Gaithers­burg, MD, where we re­port­ed last week that the com­pa­ny has been culling the ranks at Med­Im­mune as part of a com­pa­ny-wide ef­fort to shift more re­sources in­to on­col­o­gy.

In this case, it’s the neu­ro­science team that is feel­ing the ef­fects of the com­pa­ny’s ef­forts to “ap­pro­pri­ate­ly size” its glob­al R&D force.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.